Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Xiao Bin Zheng"'
Publikováno v:
Annals of Noninvasive Electrocardiology, Vol 29, Iss 3, Pp n/a-n/a (2024)
Abstract Objective To assess electrocardiogram (ECG) for risk stratification in inferior ST‐elevation myocardial infarction (STEMI) patients within 24 h. Methods Three hundred thirty‐four patients were divided into four ECG‐based groups: Group
Externí odkaz:
https://doaj.org/article/b795ac171d43401fbe3a9c25a3b2f28b
Autor:
Li Xiong, Hua-shan Liu, Chi Zhou, Xin Yang, Liang Huang, Hai-qing Jie, Zi-wei Zeng, Xiao-bin Zheng, Wen-xin Li, Zhan-zhen Liu, Liang Kang, Zhen-xing Liang
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background Hypoxia is a hallmark of solid tumors and leads to the metabolic reprogramming of cancer cells. The role of epigenetic regulation between hypoxia and aberrant cholesterol metabolism in colorectal cancer (CRC) remains elusive. Meth
Externí odkaz:
https://doaj.org/article/d9cd8b355b4a4170b2e125df858614c3
Autor:
Jing Lin, Jun Liu, Shi-guang Hao, Bin Lan, Xiao-bin Zheng, Jia-ni Xiong, Ying-qian Zhang, Xuan Gao, Chuan-ben Chen, Ling Chen, Yu-fang Huang, Hong Luo, Yu-ting Yi, Xin Yi, Jian-ping Lu, Xiong-wei Zheng, Gang Chen, Xue-feng Wang, Yu Chen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundThis study aimed to develop a vaccine that targets mutation-derived neoantigen in Chinese non-small-cell lung cancer (NSCLC).MethodsA cohort of 1862 Chinese NSCLC patients who underwent targeted sequencing with a 1021-gene panel was investi
Externí odkaz:
https://doaj.org/article/2120231c800146d5ab277713885b52c6
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Metformin is the first-line anti-diabetic drug for type 2 diabetes. It has been found to significantly reduce liver aminotransferase in nonalcoholic fatty liver disease (NAFLD). However, whether metformin improves NAFLD progression remains controvers
Externí odkaz:
https://doaj.org/article/b840cddf6a3c4151bc7fe8b3e319d6f4
Autor:
Yi-Tai Xiao, Chao Zhou, Jia-Cong Ye, Xiao-Chun Yang, Zhi-Jian Li, Xiao-Bin Zheng, Yan Mei, Xin-Ling Li, Wei-Guang Zhang, Wei Fan, Mu-Sheng Zeng, Jian-Jun Li, Guo-Kai Feng
Publikováno v:
ACS Omega, Vol 4, Iss 13, Pp 15560-15566 (2019)
Externí odkaz:
https://doaj.org/article/4901d65111904811beb4d6b0d1cea95d
Autor:
Yan Mei, Ying‐He Li, Xiao‐Chun Yang, Chao Zhou, Zhi‐Jian Li, Xiao‐Bin Zheng, Jia‐Cong Ye, Cheng Li, Xuan‐Hong Zhang, Jian‐Min Yuan, Hui‐Qiang Huang, Wei Fan, Wei‐Guang Zhang, Mu‐Sheng Zeng, Guo‐Kai Feng
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 4, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/a5c6034ba06c4026957daa8416fe233e
Autor:
Dong Chen, Xing-liang Li, Biao Wu, Xiao-bin Zheng, Wen-xian Wang, Hua-fei Chen, Yi-yu Dong, Chun-wei Xu, Mei-yu Fang
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Introduction: Oncogenic mutations in the epidermal growth factor receptor (EGFR) occur frequently in patients with lung cancer. These mutations may serve as critical predictive biomarkers in patients with non-small cell lung cancer (NSCLC). Among the
Externí odkaz:
https://doaj.org/article/fc4d846b0f4b4182aeba9c4455ceadd0
Autor:
Zhen-Xing Liang, Hua-Shan Liu, Li Xiong, Zi-Wei Zeng, Xiao-Bin Zheng, Liang Kang, Ping Lan, Xian-Rui Wu
Publikováno v:
Journal of Crohn's and Colitis. 17:289-301
Background and Aims Stem cell therapy is a promising cell-based treatment modality for inflammatory bowel diseases [IBD], but its application is limited by the nature of cell heterogeneity. Methods Single-cell RNA-sequencing was performed on the adip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4047ec8a816bc5275eaf555949620e
https://doi.org/10.1093/ecco-jcc/jjac123
https://doi.org/10.1093/ecco-jcc/jjac123
Autor:
Rui-yan Xie, Xue-ling Fang, Xiao-bin Zheng, Wei-ze Lv, Yi-jie Li, Hamze Ibrahim Rage, Qiao-lan He, Wei-ping Zhu, Tong-xia Cui
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 118, Iss , Pp - (2019)
Increasing research indicates that hyperglycemia plays a crucial role in the progression of diabetic nephropathy (DN); however, effective treatment for preventing or slowing DN progression are seriously lacking. Although salidroside (SAL) has been de
Externí odkaz:
https://doaj.org/article/aac751b7a24342d68b1eb2c3d17066e3
Publikováno v:
Applied Energy. 340:121003
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ba77cc5a86a9dedc4ce181e3f8e0162
https://doi.org/10.1016/j.apenergy.2023.121003
https://doi.org/10.1016/j.apenergy.2023.121003